HEADER LIGASE 06-MAR-23 8CQE TITLE PVHL:ELOB:ELOC IN COMPLEX WITH (2S,4R)-1-((S)-2-(1-FLUOROCYCLOPROPANE- TITLE 2 1-CARBOXAMIDO)-3,3-DIMETHYLBUTANOYL)-4-HYDROXY-N-((S)-1-(2-METHYL-4- TITLE 3 (4-METHYLTHIAZOL-5-YL)PHENYL)ETHYL)PYRROLIDINE-2-CARBOXAMIDE TITLE 4 (COMPOUND 37) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGIN-B; COMPND 3 CHAIN: A, D, G, J; COMPND 4 SYNONYM: ELOB,ELONGIN 18 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 5 FACTOR SIII SUBUNIT B,SIII P18,TRANSCRIPTION ELONGATION FACTOR B COMPND 6 POLYPEPTIDE 2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ELONGIN-C; COMPND 10 CHAIN: B, E, H, K; COMPND 11 SYNONYM: ELOC,ELONGIN 15 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 12 FACTOR SIII SUBUNIT C,SIII P15,TRANSCRIPTION ELONGATION FACTOR B COMPND 13 POLYPEPTIDE 1; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR; COMPND 17 CHAIN: C, F, I, L; COMPND 18 SYNONYM: PROTEIN G7,PVHL; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ELOB, TCEB2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ELOC, TCEB1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: VHL; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 21 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS INHIBITOR, E3 LIGASE COMPLEX, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR R.CASEMENT,L.PHUONG VU,A.CIULLI,M.GUTSCHOW REVDAT 2 11-OCT-23 8CQE 1 JRNL REVDAT 1 27-SEP-23 8CQE 0 JRNL AUTH L.P.VU,C.J.DIEHL,R.CASEMENT,A.G.BOND,C.STEINEBACH,N.STRASEK, JRNL AUTH 2 A.BRICELJ,A.PERDIH,G.SCHNAKENBURG,I.SOSIC,A.CIULLI, JRNL AUTH 3 M.GUTSCHOW JRNL TITL EXPANDING THE STRUCTURAL DIVERSITY AT THE PHENYLENE CORE OF JRNL TITL 2 LIGANDS FOR THE VON HIPPEL-LINDAU E3 UBIQUITIN LIGASE: JRNL TITL 3 DEVELOPMENT OF HIGHLY POTENT HYPOXIA-INDUCIBLE FACTOR-1 JRNL TITL 4 ALPHA STABILIZERS. JRNL REF J.MED.CHEM. V. 66 12776 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37708384 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00434 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 90.05 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 38308 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.245 REMARK 3 R VALUE (WORKING SET) : 0.243 REMARK 3 FREE R VALUE : 0.297 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1923 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 90.0500 - 6.8600 0.98 2818 164 0.2379 0.3173 REMARK 3 2 6.8600 - 5.4500 0.99 2669 134 0.2680 0.3269 REMARK 3 3 5.4500 - 4.7600 0.99 2637 140 0.2137 0.2552 REMARK 3 4 4.7600 - 4.3200 1.00 2612 143 0.1848 0.2373 REMARK 3 5 4.3200 - 4.0100 1.00 2589 136 0.2021 0.2601 REMARK 3 6 4.0100 - 3.7800 1.00 2568 147 0.2183 0.2593 REMARK 3 7 3.7800 - 3.5900 1.00 2572 143 0.2359 0.2741 REMARK 3 8 3.5900 - 3.4300 1.00 2558 157 0.2492 0.3321 REMARK 3 9 3.4300 - 3.3000 1.00 2565 129 0.2654 0.3061 REMARK 3 10 3.3000 - 3.1900 1.00 2579 121 0.2850 0.3315 REMARK 3 11 3.1900 - 3.0900 1.00 2578 117 0.2871 0.3677 REMARK 3 12 3.0900 - 3.0000 1.00 2533 126 0.2930 0.3017 REMARK 3 13 3.0000 - 2.9200 1.00 2551 120 0.3075 0.3785 REMARK 3 14 2.9200 - 2.8500 1.00 2556 146 0.3329 0.3791 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.120 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 10756 REMARK 3 ANGLE : 0.949 14688 REMARK 3 CHIRALITY : 0.054 1698 REMARK 3 PLANARITY : 0.007 1896 REMARK 3 DIHEDRAL : 15.200 1576 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8CQE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1292128996. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUL-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0-6.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 1.0.5 REMARK 200 DATA SCALING SOFTWARE : AIMLESS VERSION 0.7.8 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38541 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 181.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 25.50 REMARK 200 R MERGE (I) : 0.89700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 25.80 REMARK 200 R MERGE FOR SHELL (I) : 4.70400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 1.20.1-4487 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CACODYLATE, PH 6.0-6.3, REMARK 280 15-20% POLYETHYLENE GLYCOL 3350, 0.2 M MAGNESIUM ACETATE, 10 MM REMARK 280 DTT, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 181.02350 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 46.48550 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 46.48550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.51175 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 46.48550 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 46.48550 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 271.53525 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 46.48550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 46.48550 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 90.51175 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 46.48550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 46.48550 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 271.53525 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 181.02350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 48 REMARK 465 PRO B 49 REMARK 465 GLY B 50 REMARK 465 GLN B 51 REMARK 465 PHE B 52 REMARK 465 ALA B 53 REMARK 465 GLU B 54 REMARK 465 ASN B 55 REMARK 465 GLY C 52 REMARK 465 SER C 53 REMARK 465 MET C 54 REMARK 465 GLU C 55 REMARK 465 ALA C 56 REMARK 465 GLY C 57 REMARK 465 ARG C 58 REMARK 465 PRO C 59 REMARK 465 ARG C 60 REMARK 465 PRO C 61 REMARK 465 GLN C 203 REMARK 465 GLU C 204 REMARK 465 ARG C 205 REMARK 465 ILE C 206 REMARK 465 ALA C 207 REMARK 465 HIS C 208 REMARK 465 GLN C 209 REMARK 465 ARG C 210 REMARK 465 MET C 211 REMARK 465 GLY C 212 REMARK 465 ASP C 213 REMARK 465 GLY E 48 REMARK 465 PRO E 49 REMARK 465 GLY E 50 REMARK 465 GLN E 51 REMARK 465 PHE E 52 REMARK 465 ALA E 53 REMARK 465 GLU E 54 REMARK 465 ASN E 55 REMARK 465 GLY F 52 REMARK 465 SER F 53 REMARK 465 MET F 54 REMARK 465 GLU F 55 REMARK 465 ALA F 56 REMARK 465 GLY F 57 REMARK 465 ARG F 58 REMARK 465 PRO F 59 REMARK 465 ARG F 60 REMARK 465 PRO F 61 REMARK 465 GLN F 203 REMARK 465 GLU F 204 REMARK 465 ARG F 205 REMARK 465 ILE F 206 REMARK 465 ALA F 207 REMARK 465 HIS F 208 REMARK 465 GLN F 209 REMARK 465 ARG F 210 REMARK 465 MET F 211 REMARK 465 GLY F 212 REMARK 465 ASP F 213 REMARK 465 MET H 16 REMARK 465 GLY H 48 REMARK 465 PRO H 49 REMARK 465 GLY H 50 REMARK 465 GLN H 51 REMARK 465 PHE H 52 REMARK 465 ALA H 53 REMARK 465 GLU H 54 REMARK 465 ASN H 55 REMARK 465 GLU H 56 REMARK 465 THR H 57 REMARK 465 GLY I 52 REMARK 465 SER I 53 REMARK 465 MET I 54 REMARK 465 GLU I 55 REMARK 465 ALA I 56 REMARK 465 GLY I 57 REMARK 465 ARG I 58 REMARK 465 PRO I 59 REMARK 465 ARG I 60 REMARK 465 PRO I 61 REMARK 465 ARG I 205 REMARK 465 ILE I 206 REMARK 465 ALA I 207 REMARK 465 HIS I 208 REMARK 465 GLN I 209 REMARK 465 ARG I 210 REMARK 465 MET I 211 REMARK 465 GLY I 212 REMARK 465 ASP I 213 REMARK 465 MET K 16 REMARK 465 GLY K 48 REMARK 465 PRO K 49 REMARK 465 GLY K 50 REMARK 465 GLN K 51 REMARK 465 PHE K 52 REMARK 465 ALA K 53 REMARK 465 GLU K 54 REMARK 465 ASN K 55 REMARK 465 GLU K 56 REMARK 465 THR K 57 REMARK 465 GLY L 52 REMARK 465 SER L 53 REMARK 465 MET L 54 REMARK 465 GLU L 55 REMARK 465 ALA L 56 REMARK 465 GLY L 57 REMARK 465 ARG L 58 REMARK 465 PRO L 59 REMARK 465 ARG L 60 REMARK 465 PRO L 61 REMARK 465 GLN L 203 REMARK 465 GLU L 204 REMARK 465 ARG L 205 REMARK 465 ILE L 206 REMARK 465 ALA L 207 REMARK 465 HIS L 208 REMARK 465 GLN L 209 REMARK 465 ARG L 210 REMARK 465 MET L 211 REMARK 465 GLY L 212 REMARK 465 ASP L 213 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 19 CG CD CE NZ REMARK 470 ARG A 80 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 82 CG OD1 OD2 REMARK 470 ASP A 83 CG OD1 OD2 REMARK 470 LYS A 104 CG CD CE NZ REMARK 470 MET B 17 CG SD CE REMARK 470 GLU B 34 CG CD OE1 OE2 REMARK 470 SER B 47 OG REMARK 470 GLU B 56 CG CD OE1 OE2 REMARK 470 THR B 57 OG1 CG2 REMARK 470 ASN B 58 CG OD1 ND2 REMARK 470 ARG B 63 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 82 CG CD NE CZ NH1 NH2 REMARK 470 THR B 88 OG1 CG2 REMARK 470 ASP B 111 CG OD1 OD2 REMARK 470 VAL C 62 CG1 CG2 REMARK 470 GLN C 132 CG CD OE1 NE2 REMARK 470 VAL C 142 CG1 CG2 REMARK 470 ASP C 143 CG OD1 OD2 REMARK 470 LYS C 171 CG CD CE NZ REMARK 470 ARG C 182 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 195 CG CD OE1 NE2 REMARK 470 LYS C 196 CG CD CE NZ REMARK 470 ARG C 200 CG CD NE CZ NH1 NH2 REMARK 470 LEU C 201 CG CD1 CD2 REMARK 470 ASP D 82 CG OD1 OD2 REMARK 470 ASP D 83 CG OD1 OD2 REMARK 470 GLU D 98 CG CD OE1 OE2 REMARK 470 ASP D 101 CG OD1 OD2 REMARK 470 LYS D 104 CG CD CE NZ REMARK 470 GLU E 34 CG CD OE1 OE2 REMARK 470 LYS E 43 CG CD CE NZ REMARK 470 SER E 47 OG REMARK 470 GLU E 56 CG CD OE1 OE2 REMARK 470 THR E 57 OG1 CG2 REMARK 470 GLU E 59 CG CD OE1 OE2 REMARK 470 THR E 88 OG1 CG2 REMARK 470 ASP E 111 CG OD1 OD2 REMARK 470 VAL F 62 CG1 CG2 REMARK 470 GLU F 70 CG CD OE1 OE2 REMARK 470 ARG F 113 CG CD NE CZ NH1 NH2 REMARK 470 GLN F 132 CG CD OE1 NE2 REMARK 470 LEU F 135 CG CD1 CD2 REMARK 470 VAL F 142 CG1 CG2 REMARK 470 ASP F 143 CG OD1 OD2 REMARK 470 ARG F 182 CG CD NE CZ NH1 NH2 REMARK 470 TYR F 185 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU F 186 CG CD OE1 OE2 REMARK 470 LYS F 196 CG CD CE NZ REMARK 470 ARG F 200 CG CD NE CZ NH1 NH2 REMARK 470 LEU F 201 CG CD1 CD2 REMARK 470 MET G 1 CG SD CE REMARK 470 LYS G 46 CG CD CE NZ REMARK 470 ASP G 82 CG OD1 OD2 REMARK 470 GLU G 98 CG CD OE1 OE2 REMARK 470 LYS G 104 CG CD CE NZ REMARK 470 MET H 17 CG SD CE REMARK 470 ARG H 33 CG CD NE CZ NH1 NH2 REMARK 470 LYS H 43 CG CD CE NZ REMARK 470 SER H 47 OG REMARK 470 ASN H 58 CG OD1 ND2 REMARK 470 VAL I 62 CG1 CG2 REMARK 470 VAL I 142 CG1 CG2 REMARK 470 ASP I 143 CG OD1 OD2 REMARK 470 GLN I 145 CG CD OE1 NE2 REMARK 470 LYS I 171 CG CD CE NZ REMARK 470 ARG I 177 CG CD NE CZ NH1 NH2 REMARK 470 ASP I 179 CG OD1 OD2 REMARK 470 ILE I 180 CG1 CG2 CD1 REMARK 470 VAL I 181 CG1 CG2 REMARK 470 TYR I 185 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN I 195 CG CD OE1 NE2 REMARK 470 GLU I 199 CG CD OE1 OE2 REMARK 470 ARG I 200 CG CD NE CZ NH1 NH2 REMARK 470 LEU I 201 CG CD1 CD2 REMARK 470 THR I 202 OG1 CG2 REMARK 470 GLN I 203 CG CD OE1 NE2 REMARK 470 GLU I 204 CG CD OE1 OE2 REMARK 470 MET J 1 CG SD CE REMARK 470 ARG J 9 CG CD NE CZ NH1 NH2 REMARK 470 LYS J 36 CG CD CE NZ REMARK 470 ASP J 40 CG OD1 OD2 REMARK 470 ARG J 43 CG CD NE CZ NH1 NH2 REMARK 470 LYS J 46 CG CD CE NZ REMARK 470 GLN J 65 CG CD OE1 NE2 REMARK 470 ARG J 80 CG CD NE CZ NH1 NH2 REMARK 470 ASP J 82 CG OD1 OD2 REMARK 470 ASP J 83 CG OD1 OD2 REMARK 470 GLU J 91 CG CD OE1 OE2 REMARK 470 GLU J 98 CG CD OE1 OE2 REMARK 470 LEU J 99 CG CD1 CD2 REMARK 470 LYS J 104 CG CD CE NZ REMARK 470 MET K 17 CG SD CE REMARK 470 LYS K 43 CG CD CE NZ REMARK 470 SER K 47 OG REMARK 470 ARG K 63 CG CD NE CZ NH1 NH2 REMARK 470 GLU K 64 CG CD OE1 OE2 REMARK 470 VAL L 62 CG1 CG2 REMARK 470 VAL L 142 CG1 CG2 REMARK 470 ASP L 143 CG OD1 OD2 REMARK 470 GLN L 145 CG CD OE1 NE2 REMARK 470 GLU L 160 CG CD OE1 OE2 REMARK 470 LYS L 171 CG CD CE NZ REMARK 470 ARG L 177 CG CD NE CZ NH1 NH2 REMARK 470 ARG L 182 CG CD NE CZ NH1 NH2 REMARK 470 TYR L 185 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU L 186 CG CD OE1 OE2 REMARK 470 GLU L 189 CG CD OE1 OE2 REMARK 470 GLN L 195 CG CD OE1 NE2 REMARK 470 LYS L 196 CG CD CE NZ REMARK 470 ARG L 200 CG CD NE CZ NH1 NH2 REMARK 470 LEU L 201 CG CD1 CD2 REMARK 470 THR L 202 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 10 -124.31 56.52 REMARK 500 ASP A 47 -123.91 61.86 REMARK 500 ALA A 71 76.46 -158.01 REMARK 500 ASP A 82 -116.23 -138.39 REMARK 500 ASN B 85 61.29 64.69 REMARK 500 ASN C 90 -177.41 -69.92 REMARK 500 SER C 139 -168.23 -113.16 REMARK 500 PRO C 192 133.29 -35.92 REMARK 500 HIS D 10 -124.21 56.81 REMARK 500 ASP D 47 -120.22 57.04 REMARK 500 ALA D 71 75.80 -155.20 REMARK 500 ASP D 82 -115.73 63.13 REMARK 500 ARG F 79 39.37 -99.66 REMARK 500 SER F 139 -167.59 -114.21 REMARK 500 ASP F 190 83.48 -68.91 REMARK 500 HIS G 10 -125.23 63.07 REMARK 500 ASP G 47 -123.45 63.69 REMARK 500 ALA G 71 75.59 -156.06 REMARK 500 ASP G 82 -80.22 65.99 REMARK 500 ASN I 67 78.79 -68.66 REMARK 500 SER I 72 110.98 -164.67 REMARK 500 ARG I 79 53.61 -92.88 REMARK 500 SER I 111 -159.47 -106.77 REMARK 500 SER I 139 -168.14 -119.90 REMARK 500 ASP I 143 19.25 59.34 REMARK 500 HIS J 10 -124.62 58.43 REMARK 500 ASP J 47 -117.35 55.47 REMARK 500 ALA J 71 75.69 -158.69 REMARK 500 ASP J 82 -113.09 59.60 REMARK 500 ARG L 79 38.23 -99.81 REMARK 500 SER L 139 -166.14 -114.53 REMARK 500 REMARK 500 REMARK: NULL DBREF 8CQE A 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 8CQE B 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8CQE C 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 8CQE D 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 8CQE E 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8CQE F 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 8CQE G 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 8CQE H 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8CQE I 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 8CQE J 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 8CQE K 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8CQE L 54 213 UNP P40337 VHL_HUMAN 54 213 SEQADV 8CQE MET B 16 UNP Q15369 INITIATING METHIONINE SEQADV 8CQE GLY C 52 UNP P40337 EXPRESSION TAG SEQADV 8CQE SER C 53 UNP P40337 EXPRESSION TAG SEQADV 8CQE MET E 16 UNP Q15369 INITIATING METHIONINE SEQADV 8CQE GLY F 52 UNP P40337 EXPRESSION TAG SEQADV 8CQE SER F 53 UNP P40337 EXPRESSION TAG SEQADV 8CQE MET H 16 UNP Q15369 INITIATING METHIONINE SEQADV 8CQE GLY I 52 UNP P40337 EXPRESSION TAG SEQADV 8CQE SER I 53 UNP P40337 EXPRESSION TAG SEQADV 8CQE MET K 16 UNP Q15369 INITIATING METHIONINE SEQADV 8CQE GLY L 52 UNP P40337 EXPRESSION TAG SEQADV 8CQE SER L 53 UNP P40337 EXPRESSION TAG SEQRES 1 A 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 A 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 A 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 A 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 A 104 ASP GLY LYS THR LEU GLY GLU CAS GLY PHE THR SER GLN SEQRES 6 A 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 A 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CAS ILE GLU SEQRES 8 A 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 B 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 B 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 B 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 B 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 B 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 B 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 B 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 B 97 ALA ASN PHE LEU ASP CYS SEQRES 1 C 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 C 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CAS SEQRES 3 C 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 C 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 C 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 C 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 C 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 C 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 C 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 C 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 C 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 C 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 C 162 HIS GLN ARG MET GLY ASP SEQRES 1 D 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 D 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 D 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 D 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 D 104 ASP GLY LYS THR LEU GLY GLU CAS GLY PHE THR SER GLN SEQRES 6 D 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 D 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CAS ILE GLU SEQRES 8 D 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 E 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 E 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 E 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 E 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 E 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 E 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 E 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 E 97 ALA ASN PHE LEU ASP CYS SEQRES 1 F 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 F 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CAS SEQRES 3 F 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 F 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 F 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 F 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 F 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 F 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 F 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 F 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 F 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 F 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 F 162 HIS GLN ARG MET GLY ASP SEQRES 1 G 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 G 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 G 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 G 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 G 104 ASP GLY LYS THR LEU GLY GLU CAS GLY PHE THR SER GLN SEQRES 6 G 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 G 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CAS ILE GLU SEQRES 8 G 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 H 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 H 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 H 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 H 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 H 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 H 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 H 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 H 97 ALA ASN PHE LEU ASP CYS SEQRES 1 I 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 I 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CAS SEQRES 3 I 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 I 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 I 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 I 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 I 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 I 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 I 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 I 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 I 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 I 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 I 162 HIS GLN ARG MET GLY ASP SEQRES 1 J 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 J 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 J 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 J 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 J 104 ASP GLY LYS THR LEU GLY GLU CAS GLY PHE THR SER GLN SEQRES 6 J 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 J 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CAS ILE GLU SEQRES 8 J 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 K 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 K 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 K 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 K 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 K 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 K 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 K 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 K 97 ALA ASN PHE LEU ASP CYS SEQRES 1 L 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 L 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CAS SEQRES 3 L 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 L 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 L 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 L 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 L 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 L 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 L 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 L 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 L 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 L 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 L 162 HIS GLN ARG MET GLY ASP MODRES 8CQE CAS A 60 CYS MODIFIED RESIDUE MODRES 8CQE CAS A 89 CYS MODIFIED RESIDUE MODRES 8CQE CAS C 77 CYS MODIFIED RESIDUE MODRES 8CQE CAS D 60 CYS MODIFIED RESIDUE MODRES 8CQE CAS D 89 CYS MODIFIED RESIDUE MODRES 8CQE CAS F 77 CYS MODIFIED RESIDUE MODRES 8CQE CAS G 60 CYS MODIFIED RESIDUE MODRES 8CQE CAS G 89 CYS MODIFIED RESIDUE MODRES 8CQE CAS I 77 CYS MODIFIED RESIDUE MODRES 8CQE CAS J 60 CYS MODIFIED RESIDUE MODRES 8CQE CAS J 89 CYS MODIFIED RESIDUE MODRES 8CQE CAS L 77 CYS MODIFIED RESIDUE HET CAS A 60 9 HET CAS A 89 9 HET CAS C 77 9 HET CAS D 60 9 HET CAS D 89 9 HET CAS F 77 9 HET CAS G 60 9 HET CAS G 89 9 HET CAS I 77 9 HET CAS J 60 9 HET CAS J 89 9 HET CAS L 77 9 HET VFO C 301 40 HET VFO F 301 40 HET VFO I 301 40 HET VFO L 301 40 HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE HETNAM VFO (2~{S},4~{R})-1-[(2~{S})-2-[(1-FLUORANYLCYCLOPROPYL) HETNAM 2 VFO CARBONYLAMINO]-3,3-DIMETHYL-BUTANOYL]-~{N}-[(1~{S})-7- HETNAM 3 VFO FLUORANYL-6-(4-METHYL-1,3-THIAZOL-5-YL)-1,2,3,4- HETNAM 4 VFO TETRAHYDRONAPHTHALEN-1-YL]-4-OXIDANYL-PYRROLIDINE-2- HETNAM 5 VFO CARBOXAMIDE FORMUL 1 CAS 12(C5 H12 AS N O2 S) FORMUL 13 VFO 4(C29 H36 F2 N4 O4 S) FORMUL 17 HOH *5(H2 O) HELIX 1 AA1 THR A 23 LYS A 36 1 14 HELIX 2 AA2 PRO A 38 ASP A 40 5 3 HELIX 3 AA3 ARG B 33 LEU B 37 1 5 HELIX 4 AA4 SER B 39 SER B 47 1 9 HELIX 5 AA5 PRO B 66 THR B 84 1 19 HELIX 6 AA6 ALA B 96 ASP B 111 1 16 HELIX 7 AA7 THR C 157 VAL C 170 1 14 HELIX 8 AA8 LYS C 171 TYR C 175 5 5 HELIX 9 AA9 VAL C 181 ASP C 190 1 10 HELIX 10 AB1 ASN C 193 THR C 202 1 10 HELIX 11 AB2 THR D 23 LYS D 36 1 14 HELIX 12 AB3 PRO D 38 ASP D 40 5 3 HELIX 13 AB4 ARG E 33 LEU E 37 1 5 HELIX 14 AB5 SER E 39 SER E 47 1 9 HELIX 15 AB6 PRO E 66 THR E 84 1 19 HELIX 16 AB7 ALA E 96 GLU E 98 5 3 HELIX 17 AB8 ILE E 99 ASP E 111 1 13 HELIX 18 AB9 THR F 157 VAL F 170 1 14 HELIX 19 AC1 LYS F 171 LEU F 178 5 8 HELIX 20 AC2 VAL F 181 ASP F 190 1 10 HELIX 21 AC3 ASN F 193 THR F 202 1 10 HELIX 22 AC4 THR G 23 LYS G 36 1 14 HELIX 23 AC5 PRO G 38 ASP G 40 5 3 HELIX 24 AC6 ARG H 33 LEU H 37 1 5 HELIX 25 AC7 SER H 39 SER H 47 1 9 HELIX 26 AC8 PRO H 66 THR H 84 1 19 HELIX 27 AC9 ALA H 96 GLU H 98 5 3 HELIX 28 AD1 ILE H 99 ASP H 111 1 13 HELIX 29 AD2 ASN I 141 GLN I 145 5 5 HELIX 30 AD3 THR I 157 VAL I 170 1 14 HELIX 31 AD4 LYS I 171 LEU I 178 5 8 HELIX 32 AD5 VAL I 181 ASP I 190 1 10 HELIX 33 AD6 VAL I 194 GLN I 203 1 10 HELIX 34 AD7 THR J 23 LYS J 36 1 14 HELIX 35 AD8 PRO J 38 ASP J 40 5 3 HELIX 36 AD9 ARG K 33 LEU K 37 1 5 HELIX 37 AE1 SER K 39 SER K 47 1 9 HELIX 38 AE2 PRO K 66 THR K 84 1 19 HELIX 39 AE3 ALA K 96 GLU K 98 5 3 HELIX 40 AE4 ILE K 99 ASP K 111 1 13 HELIX 41 AE5 THR L 157 VAL L 170 1 14 HELIX 42 AE6 LYS L 171 ARG L 176 5 6 HELIX 43 AE7 VAL L 181 ASP L 190 1 10 HELIX 44 AE8 ASN L 193 THR L 202 1 10 SHEET 1 AA1 8 GLN A 49 LEU A 50 0 SHEET 2 AA1 8 GLN A 42 LYS A 46 -1 N LYS A 46 O GLN A 49 SHEET 3 AA1 8 ALA A 73 PHE A 79 -1 O GLY A 76 N TYR A 45 SHEET 4 AA1 8 ASP A 2 ARG A 9 1 N MET A 6 O VAL A 75 SHEET 5 AA1 8 THR A 12 LYS A 19 -1 O THR A 16 N LEU A 5 SHEET 6 AA1 8 GLU B 28 LYS B 32 1 O ILE B 30 N THR A 13 SHEET 7 AA1 8 TYR B 18 ILE B 22 -1 N VAL B 19 O VAL B 31 SHEET 8 AA1 8 GLU B 59 ASN B 61 1 O VAL B 60 N ILE B 22 SHEET 1 AA2 4 GLY C 106 TYR C 112 0 SHEET 2 AA2 4 PRO C 71 ASN C 78 -1 N VAL C 74 O ILE C 109 SHEET 3 AA2 4 ILE C 147 THR C 152 1 O ILE C 151 N CAS C 77 SHEET 4 AA2 4 LEU C 129 VAL C 130 -1 N LEU C 129 O THR C 152 SHEET 1 AA3 3 PRO C 95 PRO C 97 0 SHEET 2 AA3 3 VAL C 84 LEU C 89 -1 N TRP C 88 O GLN C 96 SHEET 3 AA3 3 LEU C 116 ASP C 121 -1 O LEU C 118 N VAL C 87 SHEET 1 AA4 4 GLN D 49 LEU D 50 0 SHEET 2 AA4 4 GLN D 42 LYS D 46 -1 N LYS D 46 O GLN D 49 SHEET 3 AA4 4 ALA D 73 ALA D 81 -1 O GLY D 76 N TYR D 45 SHEET 4 AA4 4 THR D 84 PHE D 85 -1 O THR D 84 N ALA D 81 SHEET 1 AA5 8 GLN D 49 LEU D 50 0 SHEET 2 AA5 8 GLN D 42 LYS D 46 -1 N LYS D 46 O GLN D 49 SHEET 3 AA5 8 ALA D 73 ALA D 81 -1 O GLY D 76 N TYR D 45 SHEET 4 AA5 8 ASP D 2 ARG D 9 1 N MET D 6 O VAL D 75 SHEET 5 AA5 8 THR D 12 LYS D 19 -1 O THR D 16 N LEU D 5 SHEET 6 AA5 8 GLU E 28 LYS E 32 1 O ILE E 30 N THR D 13 SHEET 7 AA5 8 TYR E 18 ILE E 22 -1 N LEU E 21 O PHE E 29 SHEET 8 AA5 8 GLU E 59 ASN E 61 1 O VAL E 60 N ILE E 22 SHEET 1 AA6 7 PRO F 95 PRO F 97 0 SHEET 2 AA6 7 VAL F 84 LEU F 89 -1 N TRP F 88 O GLN F 96 SHEET 3 AA6 7 LEU F 116 ASP F 121 -1 O ARG F 120 N LEU F 85 SHEET 4 AA6 7 GLY F 127 VAL F 130 -1 O LEU F 128 N PHE F 119 SHEET 5 AA6 7 ILE F 147 THR F 152 -1 O THR F 152 N LEU F 129 SHEET 6 AA6 7 PRO F 71 ASN F 78 1 N ILE F 75 O ALA F 149 SHEET 7 AA6 7 GLY F 106 TYR F 112 -1 O ILE F 109 N VAL F 74 SHEET 1 AA7 4 GLN G 49 LEU G 50 0 SHEET 2 AA7 4 GLN G 42 LYS G 46 -1 N LYS G 46 O GLN G 49 SHEET 3 AA7 4 ALA G 73 ALA G 81 -1 O GLY G 76 N TYR G 45 SHEET 4 AA7 4 THR G 84 PHE G 85 -1 O THR G 84 N ALA G 81 SHEET 1 AA8 8 GLN G 49 LEU G 50 0 SHEET 2 AA8 8 GLN G 42 LYS G 46 -1 N LYS G 46 O GLN G 49 SHEET 3 AA8 8 ALA G 73 ALA G 81 -1 O GLY G 76 N TYR G 45 SHEET 4 AA8 8 ASP G 2 ARG G 9 1 N MET G 6 O VAL G 75 SHEET 5 AA8 8 THR G 12 LYS G 19 -1 O THR G 16 N LEU G 5 SHEET 6 AA8 8 GLU H 28 LYS H 32 1 O ILE H 30 N THR G 13 SHEET 7 AA8 8 TYR H 18 ILE H 22 -1 N VAL H 19 O VAL H 31 SHEET 8 AA8 8 GLU H 59 ASN H 61 1 O VAL H 60 N ILE H 22 SHEET 1 AA9 4 GLY I 106 TYR I 112 0 SHEET 2 AA9 4 PRO I 71 ARG I 79 -1 N SER I 72 O SER I 111 SHEET 3 AA9 4 ILE I 147 THR I 152 1 O ILE I 151 N CAS I 77 SHEET 4 AA9 4 LEU I 129 VAL I 130 -1 N LEU I 129 O THR I 152 SHEET 1 AB1 3 PRO I 95 PRO I 97 0 SHEET 2 AB1 3 VAL I 84 LEU I 89 -1 N TRP I 88 O GLN I 96 SHEET 3 AB1 3 LEU I 116 ASP I 121 -1 O LEU I 118 N VAL I 87 SHEET 1 AB2 4 GLN J 49 LEU J 50 0 SHEET 2 AB2 4 GLN J 42 LYS J 46 -1 N LYS J 46 O GLN J 49 SHEET 3 AB2 4 ALA J 73 ALA J 81 -1 O GLY J 76 N TYR J 45 SHEET 4 AB2 4 THR J 84 PHE J 85 -1 O THR J 84 N ALA J 81 SHEET 1 AB3 8 GLN J 49 LEU J 50 0 SHEET 2 AB3 8 GLN J 42 LYS J 46 -1 N LYS J 46 O GLN J 49 SHEET 3 AB3 8 ALA J 73 ALA J 81 -1 O GLY J 76 N TYR J 45 SHEET 4 AB3 8 ASP J 2 ARG J 9 1 N MET J 6 O VAL J 75 SHEET 5 AB3 8 THR J 12 LYS J 19 -1 O ALA J 18 N VAL J 3 SHEET 6 AB3 8 GLU K 28 LYS K 32 1 O ILE K 30 N THR J 13 SHEET 7 AB3 8 TYR K 18 ILE K 22 -1 N LEU K 21 O PHE K 29 SHEET 8 AB3 8 GLU K 59 ASN K 61 1 O VAL K 60 N ILE K 22 SHEET 1 AB4 4 GLY L 106 TYR L 112 0 SHEET 2 AB4 4 PRO L 71 ARG L 79 -1 N VAL L 74 O ILE L 109 SHEET 3 AB4 4 ILE L 147 THR L 152 1 O ILE L 151 N CAS L 77 SHEET 4 AB4 4 LEU L 129 VAL L 130 -1 N LEU L 129 O THR L 152 SHEET 1 AB5 3 PRO L 95 PRO L 97 0 SHEET 2 AB5 3 VAL L 84 LEU L 89 -1 N TRP L 88 O GLN L 96 SHEET 3 AB5 3 LEU L 116 ASP L 121 -1 O LEU L 118 N VAL L 87 LINK C GLU A 59 N CAS A 60 1555 1555 1.33 LINK C CAS A 60 N GLY A 61 1555 1555 1.33 LINK C LEU A 88 N CAS A 89 1555 1555 1.33 LINK C CAS A 89 N ILE A 90 1555 1555 1.33 LINK C PHE C 76 N CAS C 77 1555 1555 1.33 LINK C CAS C 77 N ASN C 78 1555 1555 1.33 LINK C GLU D 59 N CAS D 60 1555 1555 1.33 LINK C CAS D 60 N GLY D 61 1555 1555 1.33 LINK C LEU D 88 N CAS D 89 1555 1555 1.33 LINK C CAS D 89 N ILE D 90 1555 1555 1.33 LINK C PHE F 76 N CAS F 77 1555 1555 1.32 LINK C CAS F 77 N ASN F 78 1555 1555 1.33 LINK C GLU G 59 N CAS G 60 1555 1555 1.33 LINK C CAS G 60 N GLY G 61 1555 1555 1.33 LINK C LEU G 88 N CAS G 89 1555 1555 1.32 LINK C CAS G 89 N ILE G 90 1555 1555 1.33 LINK C PHE I 76 N CAS I 77 1555 1555 1.33 LINK C CAS I 77 N ASN I 78 1555 1555 1.33 LINK C GLU J 59 N CAS J 60 1555 1555 1.32 LINK C CAS J 60 N GLY J 61 1555 1555 1.32 LINK C LEU J 88 N CAS J 89 1555 1555 1.33 LINK C CAS J 89 N ILE J 90 1555 1555 1.33 LINK C PHE L 76 N CAS L 77 1555 1555 1.33 LINK C CAS L 77 N ASN L 78 1555 1555 1.33 CRYST1 92.971 92.971 362.047 90.00 90.00 90.00 P 41 21 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010756 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010756 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002762 0.00000